C R Benzie
Overview
Explore the profile of C R Benzie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doe S, Benzie C, Kay J
Biochem Soc Trans
. 1990 Jun;
18(3):451-2.
PMID: 1695581
No abstract available.
2.
Kay J, Moore A, Doe S, Benzie C, Schonbrunner R, Schmid F, et al.
Transplant Proc
. 1990 Feb;
22(1):96-9.
PMID: 1689914
No abstract available.
3.
Kay J, Benzie C
Immunol Lett
. 1989 Dec;
23(2):155-9.
PMID: 2483716
Nanomolar concentrations of the novel immunosuppressive drug FK-506 inhibit the proliferation of human T lymphocytes in vitro induced by mitogenic lectins or by monoclonal antibodies directed against the CD3 or...
4.
Walliser P, Benzie C, Kay J
Immunology
. 1989 Nov;
68(3):434-5.
PMID: 2480331
The novel immunosuppressive drug FK-506 inhibits both cell-mediated and humoral immunity in vivo and suppresses T-lymphocyte activation at nanamolar concentrations in vitro. We report here that FK-506 also inhibits the...
5.
Kay J, Doe S, Benzie C
Cell Immunol
. 1989 Nov;
124(1):175-81.
PMID: 2478301
The novel immunosuppressive drug FK-506 inhibits the induction of lymphocyte proliferation in vitro by mitogenic combinations of phorbol esters and calcium ionophores. Early events inducible by phorbol esters alone are...
6.
Kay J, Benzie C, Goodier M, Wick C, Doe S
Immunology
. 1989 Aug;
67(4):473-7.
PMID: 2475433
Nanamolar concentrations of the immunosuppressive drug FK-506 inhibit the induction of T-lymphocyte proliferation by the lectins concanavalin A (Con A) and phytohaemagglutinin (PHA). Activation by Con A is more sensitive...
7.
Kay J, Benzie C
Immunology
. 1986 Feb;
57(2):195-9.
PMID: 3485075
Lymphocyte activation by the mitogenic monoclonal antibody OKT3 is less effective than activation by mitogenic lectins such as phytohaemagglutinin (PHA) and concanavalin A (Con A). Activation by OKT3 is also...
8.
Kay J, Benzie C
Immunol Lett
. 1986 Jan;
12(1):55-8.
PMID: 3007339
Blockade of the transferrin receptors whose expression is induced in lymphocytes incubated with the mitogenic lectin phytohaemagglutinin (PHA) does not affect the initial stimulation of protein synthesis but does strongly...
9.
Walls E, Borghetti A, Benzie C, Kay J
Cell Immunol
. 1984 Nov;
89(1):30-8.
PMID: 6548415
The effects of the mitogenic monoclonal antibody OKT3 on the metabolic changes preceding DNA synthesis during the activation of human peripheral blood mononuclear cells were compared with those induced by...
10.
Kay J, Benzie C
Cell Immunol
. 1984 Aug;
87(1):217-24.
PMID: 6744419
The ability of the immunosuppressive drug cyclosporin A (CS-A) to inhibit the activation of lymphocytes by phytohaemagglutinin (PHA) and concanavalin A (Con A) is progressively lost over the 8-hr period...